Transgene S.A. (TRGNF) Stock Analysis
DELISTED
What happened to Transgene S.A. (TRGNF) stock?
Transgene S.A. (TRGNF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $115M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Transgene S.A. (TRGNF). Transgene SA is a French biotechnology company focused on designing and developing therapeutic vaccines and oncolytic viruses for treating cancers and infectious diseases.
Last analyzed: Mar 16, 2026These figures come from statements filed 16 months ago — the most recent this company has published.
Transgene S.A. (TRGNF) Healthcare & Pipeline Overview
TRGNF OTC Market Information
TRGNF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy TRGNF shares?
No. TRGNF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for TRGNF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before TRGNF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Transgene S.A.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.